Bharat Parenterals valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY23Mar 2023FY22Mar 2022
Price multiples — at each FY-end close
45.39×——
5.78×——
5.07×——
Enterprise multiples
5.07×——
51.73×——
71.23×——
Yield
2.2%——
−1.0%——
Reference — adjusted share basis
₹1,912.90——
₹42.14₹42.14₹36.89
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BPLPHARMA₹1,912.90

Bharat Parenterals Limited

· Pharma & Health
₹ CrorePeersJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOCMcap ₹1,105 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
Current
last close
Price Multiples — at each FY-end close
P/E——45.39
P/B——5.78
P/Sales——5.07
Enterprise Multiples
EV/Sales——5.07
EV/EBITDA——51.73
EV/EBIT——71.23
Yield
Earnings Yield %——2.20
FCF Yield %——-1.05
Reference — adjusted share basis
Price (FY-end close, adj.)——1,912.90
EPS (adj.)36.8942.1442.14
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.